1. Market Research
  2. > Healthcare
  3. > Pathology
  4. > Chronic Disease Market Trends
  5. > Neuromodulation Technologies - A Strategic Perspective (TechVision) 

Neuromodulation Technologies - A Strategic Perspective (TechVision) : Evaluating Technology's Role in Driving Strategic Transformation within Global Neuromodulation Industry

Over the past decade, global industry leaders offering neuromodulation technologies have been largely successful in implementing large scale value stream transformation programs in setting a mature cost-to-serve model. However, understanding the gaps between OEM initiatives in delivering value to care payers and payer demands have been limited. This research service offers a strategic perspective on the industry, analyzing the gaps between technology push-pull factors that are poised to enable OEMs sustain both volume growth and margin. This research also examines how OEMs can shift from a value-to-cost model to a value-to-serve business model, which plays a lead role in delivering personalized value to healthcare payers and care providers.

Key Findings

There is a significant demand for research on cardiovascular disorders, where existing participants in the market invest significant resources focusing on generating sufficient clinical evidence for conditions such as arrhythmia, ischemia and heart failure.

The recent focus of top OEMs on single-source suppliers helps in improving operational efficiency, and balancing quality, delivery, and cost. However, translation of cost-reduction efforts to payers and driving reimbursement is critical for top-line growth.

Findings of the benchmarking clearly suggest that there is a shift toward minimally-invasive and connected health technologies that enable patients to take therapy at the convenience of the physicians office or at home. Percutaneous stimulation technologies are a step in this direction.

To sustain profitable growth, OEMs must align strategic intent towards building a value-driven business model that is well differentiated in its offerings to mature markets, where cost efficiencies are transferred across the value stream.

Our analysis evaluates the real-world examples, and emerging business models where customer value is driven by early adoption and successful integration of social, mobile, analytics and networking, which is key to driving efficiency across the value stream.

Acquisitions enable OEMs to drive market growth and the forward integration moves of existing single-source suppliers could pose a threat to the profitability of OEMs.

Entry of minimal/non-invasive technologies with strong IP, regulatory approvals (CE/TGA) and strong clinical data for chronic lifestyle disorders would drive further consolidation within the market by acquisitions by OEMs, giving exit to VC/PE firms.

While OEMs continue to gain ground in establishing safety/efficacy for existing products in mature markets, their VC counterparts continue to invest early in technologies, enabling the launch of new products/services for existing markets.

OEMs have been successful in implementing large-scale value stream transformation programs to single-source suppliers; this is expected to reduce the overall cost of activities across the value chain, with a mature cost-to-serve model.



Table Of Contents

Neuromodulation Technologies - A Strategic Perspective (TechVision) 
1 EXECUTIVE SUMMARY

Executive Summary
1 Scope of Research
2 Research Methodology
3 Key Findings
4 Key Findings
5 Key Findings
6 Key Findings

2 TECHNOLOGY TRENDS and ANALYSIS

Technology Trends and Analysis
1 Snapshot of Neuromodulation Technologies
2 Snapshot of Neuromodulation Technologies
3 Snapshot of Commercial Products
4 Snapshot of Commercial Products
5 Evaluation of Technology Trends
6 Analysis of Technology Value Chain
7 Analysis of Technology Value Chain
8 Benchmarking of Neuromodulation Devices
9 Analytical Hierarchical Process (AHP)
10 Analytical Hierarchical Process (AHP)
11 Application Roadmap
12 Application Roadmap
13 Application Roadmap
14 Key Findings

3 INDUSTRY TRENDS and ANALYSIS

Industry Trends and Analysis
1 Snapshot of Global Neuromodulation Industry
2 Impact of Market Drivers and Challenges
3 Impact of Technology Drivers and Challenges
4 Analysis of Industry Investments and Strategy
5 Analysis of Industry Investments and Strategy
6 Analysis of Strategic Partnerships
7 Analysis of Strategic Partnerships
8 Analysis of Strategic Partnerships
9 Strategic Analysis of OEM Stakeholders
10 Strategic Analysis of OEM Stakeholders

4 STRATEGY ASSESSMENT

Strategy Assessment
1 Analysis of Strategic Gaps
2 Key Growth Strategies of OEMs
3 Value-for-Cost Business Model

5 ANALYST INSIGHTS

Analyst Insights
1 Value-to-Serve Business Model for OEMs
2 Analyst Insights

6 LIST OF KEY PATENTS

List of Key Patents
1 Key IP Creation Activities of OEMs
2 Key Patents (1/3)
3 Key Patents (2/3)
4 Key Patents (3/3)
5 List of Key Industry Participants
6 Legal Disclaimer

7 APPENDIX

Appendix
1 Analytical Hierarchical Process
2 Explanation of Benchmarking Criteria
3 Liberatore's Rating Scale

8 THE FROST and SULLIVAN STORY

The Frost and Sullivan Story
1 The Frost and Sullivan Story
2 Value Proposition: Future of Your Company and Career
3 Global Perspective
4 Industry Convergence
5 360º Research Perspective
6 Implementation Excellence
7 Our Blue Ocean Strategy

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation

  • $ 6995
  • Industry report
  • November 2016
  • by GBI Research

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation Summary Asthma is a chronic condition affecting ...

Global Markets for Diabetes Therapeutics and Diagnostics

Global Markets for Diabetes Therapeutics and Diagnostics

  • $ 6650
  • Industry report
  • September 2016
  • by BCC Research

Use this report to: - Analyze the market for drugs used in the treatment of diabetes, it's technology and the industry as a whole - Identify important trends and provide sales forecasts by product categories ...

Personal Mobility Devices Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2015 - 2023

Personal Mobility Devices Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2015 - 2023

  • $ 5795
  • Industry report
  • August 2016
  • by Transparency Market Research

Personal mobility devices such as wheelchairs, mobility scooters, and stair lifts have witnessed significant growth in revenue and volume in the past few years. A personal mobility device is either a manual ...


ref:plp2016

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.